SPRB – spruce biosciences, inc. (US:NASDAQ)

News

Spruce Biosciences Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]
Spruce Biosciences Reports Q3 2024 Earnings and Updates [Yahoo! Finance]
Spruce Biosciences, Inc. (NASDAQ: SPRB) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $2.00 price target on the stock.
Spruce Biosciences GAAP EPS of -$0.21 beats by $0.04 Nov. 11, 2024 12:47 PM ET By: Harsh Shukla , SA News Editor [Seeking Alpha]
Spruce Biosciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com